Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 03 Sept 2026 for Entrada Therapeutics, Inc., €16k.
Filing timeline
BuySaleNathan J. Dowden
Insider track record
Disclosed buys
0
Disclosed sells
14
Signal history
Nathan J. Dowden: trading record in brief
All filings by Nathan J. Dowden on record concern Entrada Therapeutics, Inc., in the capacity of senior executive. Between 1 March 2022 and 2 September 2026, the trades on record add up to 27 filings.
Sales make up the whole of the open-market record (14 sales, €558k). The rest of the record consists of 11 share grants and 2 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
The latest filing, published on 3 September 2026, reports a share grant of €16k in Entrada Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Nathan J. Dowden
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
2,528 shares@ US$7.14390.0070% mcap2.4% of flowCommon StockSEC:0001873392-26-000006:0
15,000 shares@ US$1.740.0090% mcap3.5% of flowCommon StockSEC:0001873392-26-000004:0
3,116 shares@ US$13.0245.5% of flowCommon StockSEC:0001873392-26-000002:0
55,800 shares0Common StockSEC:0001873392-26-000001:0
1,746 shares@ US$5.43021.3% of flowCommon StockSEC:0001873392-25-000003:0
60,800 shares0Common StockSEC:0001689375-25-000013:0
847 shares@ US$16.001.9% of flowCommon StockSEC:0001689375-24-000056:0
399 shares@ US$15.19470.8% of flowCommon StockSEC:0001689375-24-000054:0
483 shares@ US$15.76111.1% of flowCommon StockSEC:0001689375-24-000051:0
20,000 shares@ US$1.744.9% of flowCommon StockSEC:0001689375-24-000048:0
1,826 shares@ US$12.32133.2% of flowCommon StockSEC:0001689375-24-000007:0
33,100 shares0Common StockSEC:0001689375-24-000004:0
14,200 shares0Common StockSEC:0001689375-23-000061:0
3,200 shares@ US$18.00168.1% of flowCommon StockSEC:0001689375-23-000047:0
8,885 shares@ US$14.935718.9% of flowCommon StockSEC:0001689375-23-000042:0
14,200 shares0Common StockSEC:0001689375-23-000026:0
28,400 shares0Common StockSEC:0001689375-23-000012:0
2,100 shares@ US$24.04537.9% of flowCommon StockSEC:0001689375-22-000040:0
3,034 shares@ US$20.10439.5% of flowCommon StockSEC:0001689375-22-000038:0
905 shares@ US$18.07352.6% of flowCommon StockSEC:0001689375-22-000036:0
1,329 shares@ US$15.323.3% of flowCommon StockSEC:0001689375-22-000032:0
3,275 shares@ US$15.12587.8% of flowCommon StockSEC:0001689375-22-000029:0
100 shares@ US$15.010.2% of flowCommon StockSEC:0001689375-22-000027:0
912 shares@ US$15.14722.1% of flowCommon StockSEC:0001689375-22-000018:0
5,632 shares0Common StockSEC:0001104659-22-097873:0
25 of 27 declarations
